KAPA CIK: 1962011

Kairos Pharma, LTD.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY23:
0.08
FY24:
−3.96
FY25:
−3.44
Change from FY23 to FY25
millions USD
FY23:
−0.43
FY24:
5.13
FY25:
6.66
millions USD
FY23:
−0.34
FY24:
1.18
FY25:
3.22

All amounts in millions USD Data source:SEC EDGAR